SCHEMBL12450552

SCHEMBL12450552

CCC(=O)N(CC)C(=O)CC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.39
ALDH1A1 P00352 7/20 0.39
TDP1 Q9NUW8 2/20 0.39
FFAR3 O14843 1/20 0.39
SOAT1 P35610 1/20 0.36
TSHR P16473 2/20 0.32
CHRM2 P08172 1/20 0.32
CHRM4 P08173 1/20 0.32
CHRM5 P08912 1/20 0.32
CHRM1 P11229 1/20 0.32
CHRM3 P20309 1/20 0.32
GLA P06280 1/20 0.32
FDPS P14324 1/20 0.32
MMP1 P03956 1/20 0.32
MMP2 P08253 1/20 0.32
MMP3 P08254 1/20 0.32
MMP8 P22894 1/20 0.32
HSD17B10 Q99714 1/20 0.32
ALOX15 P16050 1/20 0.30
MGAM O43451 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16683559 0.85 CHRM1 (0.43) LMNAALDH1A1TDP1FFAR3SOAT1
SCHEMBL11687613 0.83 ALDH1A1 (0.36) LMNAALDH1A1TDP1FFAR3SOAT1
Hydrochloric Acid SCHEMBL11687621 0.83 FFAR3 (0.38) LMNAALDH1A1TDP1FFAR3SOAT1
SCHEMBL20195315 0.83 ALOX15 (0.36) LMNAALDH1A1TDP1FFAR3SOAT1
SCHEMBL24315414 0.81 TDP1 (0.36) LMNAALDH1A1TDP1FFAR3CHRM2
SCHEMBL24865143 0.81 SOAT1 (0.35) LMNAALDH1A1TDP1FFAR3SOAT1
SCHEMBL9074136 0.80 ALDH1A1 (0.39) LMNAALDH1A1TDP1FFAR3SOAT1
SCHEMBL21898112 0.79 LMNA (0.31) LMNA
SCHEMBL16682390 0.79 MEN1 (0.31) LMNACHRM2CHRM4CHRM5CHRM1
SCHEMBL19287881 0.79 LMNA (0.31) LMNAFDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4512794-A1 METHOD FOR PRODUCING COMPOSITION CONTAINING PURIFIED FLUORINE-CONTAINING ETHER COMPOUND DAIKIN INDUSTRIES, LTD. (JP) 2025-02-26 EP disclosed
US-20250042830-A1 METHOD FOR PRODUCING COMPOSITION CONTAINING PURIFIED FLUORINE-CONTAINING ETHER COMPOUND DAIKIN INDUSTRIES, LTD. (JP) 2025-02-06 US disclosed
CN-119032075-A Process for producing purified fluoroether compound-containing composition 大金工业株式会社 2024-11-26 CN disclosed
WO-2023204189-A1 METHOD FOR PRODUCING COMPOSITION CONTAINING PURIFIED FLUORINE-CONTAINING ETHER COMPOUND ダイキン工業株式会社 2023-10-26 WO disclosed
US-20220033503-A1 Anti PD-L1 Conjugates for Treating Tumors BIRDIE BIOPHARMACEUTICALS, INC. (KY) 2022-02-03 US disclosed
EP-3092220-B1 VITAMIN C PRODRUGS AND USES THEREOF UNIV FLORIDA (US) 2021-01-20 EP disclosed
US-20160276600-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LG CHEM, LTD. (KR) 2016-09-22 US disclosed
US-20160233432-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME LG CHEM, LTD. (KR) 2016-08-11 US disclosed
US-20160233430-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME (As Amended) LG CHEM, LTD. (KR) 2016-08-11 US disclosed
US-20160181536-A1 COPOLYMER AND ORGANIC SOLAR CELL COMPRISING SAME LG CHEM, LTD. (KR) 2016-06-23 US disclosed
US-20120238640-A9 Polymer Derivatives Comprising an Imide Branching Point NEKTAR THERAPEUTICS 2012-09-20 US disclosed
US-20080319091-A1 Polymer Derivatives Comprising an Imide Branching Point NEKTAR THERAPEUTICS AL, CORPORATION 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160233430-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME (As Amended) CRY1, CRY2, PER2 LMNA 3958/4885ALDH1A1 1790/4885TDP1 3706/4885
US-20220033503-A1 Anti PD-L1 Conjugates for Treating Tumors CD274, PDCD1LG2, PDCD1 LMNA 2642/4885ALDH1A1 564/4885TDP1 3088/4885
US-20120238640-A9 Polymer Derivatives Comprising an Imide Branching Point INCENP, ILK, PIM3 LMNA 1849/4885ALDH1A1 1949/4885TDP1 2240/4885
US-20160276600-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME SUN2, EML4, DDT LMNA 1951/4885ALDH1A1 35/4885TDP1 2775/4885
US-20250042830-A1 METHOD FOR PRODUCING COMPOSITION CONTAINING PURIFIED FLUORINE-CONTAINING ETHER COMPOUND NOX3, NOX1, NOXO1 LMNA 2673/4885ALDH1A1 3290/4885TDP1 3399/4885
US-20160233432-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME CRY1, CRY2, NR2E3 LMNA 2762/4885ALDH1A1 252/4885TDP1 3616/4885
US-20080319091-A1 Polymer Derivatives Comprising an Imide Branching Point INCENP, ILK, PIM3 LMNA 1849/4885ALDH1A1 1949/4885TDP1 2240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.